» Articles » PMID: 8110529

The Epidemiology of Vertebral Fractures. European Vertebral Osteoporosis Study Group

Overview
Journal Bone
Date 1993 Jan 1
PMID 8110529
Citations 82
Authors
Affiliations
Soon will be listed here.
Abstract

Vertebral fractures are recognised as a hallmark of osteoporosis, yet little is known of their epidemiology. This deficiency limits accurate characterisation of the public health importance of osteoporosis. Assessment of the impact of vertebral fractures has been hampered by the absence of formal criteria for identifying fractures on a thoracolumbar radiograph. Initial methods relying upon subjective radiological assessments have given way to morphometric measurements of vertebral heights, with deformities defined according to various algorithms. These methods have been used in a series of studies performed in Rochester, MN, to determine the incidence, outcome, and time trends of vertebral deformities. The results suggest a prevalence rate of vertebral deformity of 25.3 per 100 Rochester women aged 50 years and over (95% CI, 22.3-28.2), with an estimated incidence of 17.8 per 1,000 person-years. The incidence of clinically diagnosed vertebral fractures among women in the same population was 5.3 per 1,000 person-years, suggesting that around 30% of such deformities in women receive clinical attention. Morphometric measurement on the radiographs of women with clinically diagnosed fractures revealed that 80% had grade 2 ( > 4 SD) deformities. Comparable data on the occurrence and health impact of vertebral deformities throughout Europe are urgently required. The European Vertebral Osteoporosis Study (EVOS) is a multicentre epidemiological study that aims to address this issue. It is designed as a radiographic prevalence study in 34 European centres.(ABSTRACT TRUNCATED AT 250 WORDS)

Citing Articles

A nationwide cohort study of inflammatory bowel disease, histological activity and fracture risk.

Marild K, Soderling J, Axelrad J, Halfvarson J, Forss A, Michaelsson K Aliment Pharmacol Ther. 2024; 60(11-12):1549-1560.

PMID: 39308339 PMC: 11599792. DOI: 10.1111/apt.18275.


Comparison of the Clinical Efficacy of Anabolic Agents and Bisphosphonates in the Patients With Osteoporotic Vertebral Fracture: Systematic Review and Meta-analysis of Randomized Controlled Trials.

Jeon I, Park S, Moon B, Choi M, Kuh S, Kim J Neurospine. 2024; 21(2):416-429.

PMID: 38697911 PMC: 11224729. DOI: 10.14245/ns.2347256.628.


Assessment of Cement Leakage in Decompressed Percutaneous Kyphoplasty.

Cheng S, Chou W, Tsuei Y, Chu W, Chu W J Clin Med. 2024; 13(2).

PMID: 38256479 PMC: 10816848. DOI: 10.3390/jcm13020345.


Red flags to screen for vertebral fracture in patients presenting with low-back pain.

Williams C, Henschke N, Maher C, Van Tulder M, Koes B, Macaskill P Cochrane Database Syst Rev. 2023; 11:CD008643.

PMID: 38014846 PMC: 10683370. DOI: 10.1002/14651858.CD008643.pub3.


Examination and Scientific Analysis of Thoracic Vertebral Fractures.

Singh G, Rao V, Thamba A, Roth D, Zaazoue M Cureus. 2023; 15(9):e44938.

PMID: 37692185 PMC: 10492182. DOI: 10.7759/cureus.44938.